Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,876,849 papers from all fields of science
Search
Sign In
Create Free Account
Parietaria judaica pollen
Known as:
Pollinex
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Antigens, Plant
Plant Extracts
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Pollinex Quattro Tree: allergy vaccine
S. Gawchik
,
C. Saccar
2009
Corpus ID: 72561609
An overview of short-term specific immunotherapy (ST-SIT) highlighting Pollinex Quattro (PQ) Tree is presented. The product…
Expand
2005
2005
Allergoid-specific T-cell reaction as a measure of the immunological response to specific immunotherapy (SIT) with a Th1-adjuvanted allergy vaccine.
von Baehr
,
A. Hermes
,
+4 authors
S. Woroniecki
Journal of investigational allergology & clinical…
2005
Corpus ID: 37798026
BACKGROUND Specific immunotherapy (SIT) is believed to modulate CD4+ T-helper cells. In order to improve safety, SIT vaccines are…
Expand
2004
2004
Safety evaluation of a new allergy vaccine containing the adjuvant monophosphoryl lipid A (MPL®) for the treatment of grass pollen allergy
P. Baldrick
,
D. Richardson
,
A. Wheeler
,
S. Woroniecki
Journal of Applied Toxicology
2004
Corpus ID: 20399243
A novel allergy vaccine (Pollinex® Quattro) has been developed for the prevention or relief of allergic symptoms caused by a…
Expand
2001
2001
Standardisation of glutaraldehyde-modified tyrosine-adsorbed tree pollen vaccines containing the Th1-inducing adjuvant, monophosphoryl lipid A (MPL).
M. Hopkins
,
B. Lees
,
D. Richardson
,
S. Woroniecki
,
A. Wheeler
Allergologia et Immunopathologia
2001
Corpus ID: 5691933
1995
1995
Clinical effects of specific immunotheraphy in children with atopic dermatitis.
A. Trofimowicz
,
E. Rzepecka
,
J. Hofman
Roczniki Akademii Medycznej w Bialymstoku
1995
Corpus ID: 20758276
The clinical results of specific immunotheraphy using Pollinex, Catalet, or Alavac S-HDM vaccines in 22 patients with atopic…
Expand
1988
1988
Comparison of alum-precipitated aqueous extracts and modified ragweed tyrosine adsorbate vaccine in the treatment of ragweed hay fever.
J. Hébert
,
P. Small
Annals of allergy
1988
Corpus ID: 38845022
Thirty-five ragweed-sensitive patients received immunotherapy with either alum-precipitated aqueous extracts (AP) or modified…
Expand
1987
1987
Oral hyposensitisation with enteric-coated allergens as extension therapy following a basic subcutaneous course of injections.
F. Horak
,
A. Wheeler
International Archives of Allergy and Applied…
1987
Corpus ID: 41905595
We investigated in grass-pollen-sensitive adults the efficacy and safety of a therapeutic hyposensitisation regimen consisting of…
Expand
1986
1986
Human IgG antibody responses to grass pollen antigens: effects of immunotherapy and comparison of serum and secretory profiles.
M. Deards
,
R. Standring
,
D. Moran
International Archives of Allergy and Applied…
1986
Corpus ID: 28182011
IgG antibody responses, induced by individual temperate grass pollen allergens in atopic subjects, have been studied by an SDS…
Expand
1979
1979
[Multicenter controlled trial of desensitization treatment of pollen-induced hay fever and asthma with pollinex vaccine].
T. Adamek-Guzik
,
A. Szczeklik
,
J. Wołoszyński
Polski tygodnik lekarski
1979
Corpus ID: 43573818
1976
1976
Treatment of hay fever in general practice by hyposensitization, using 'Pollinex'.
J. Purser
Current Medical Research and Opinion
1976
Corpus ID: 31281455
Twenty-six patients from a general practice suffering with clear-cut seasonal rhinitis due to grass pollen were treated with 3…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE